“Real‐world” eligibility for aducanumab depends on clinical setting and patients' journey
Alessandro Padovani, Salvatore Caratozzolo, Luca Rozzini, Andrea Pilotto, Alberto Benussi, Gioacchino Tedeschi
Abstract
See related editorial by Lundebjerg et al .
Topics & Concepts
MedicineMEDLINEFamily medicineGerontologyIntensive care medicineLawPolitical scienceAcute Lymphoblastic Leukemia researchHealth Systems, Economic Evaluations, Quality of LifePharmaceutical studies and practices